Alli Weight Loss Drug Being Promoted Honestly

Written by Stuart Stevens | Tuesday, 29 May 2007

The new weight loss drug Alli that contains orlistat (the active ingredient of Xenical) is being heavily promoted in America at the moment as it is due to be stocked on the shelves of the pharmacies in the middle of June.  For example last week the license holder of the drug GlaxoSmithKline (the original patent belongs to Roche), opened up an exhibition in New York which was designed to give all the information that potential consumers of the Alli drug need to know.

The message was not all upbeat and it was not promoted as a miracle cure like so many bogus weight loss medications and supplements but just as a weight loss aid that can just give you an extra boost in shedding the pounds. GlaxoSmithKline say that if they promoted Alli as a wonder drug it would only mean that people would be disappointed by the results and would eventually stop using it. The management of GlaxoSmithKline say they are more interested in getting the correct message across to potential consumers that orlistat can work alongside a healthy eating plan and an exercise program rather then peddle false expectations.

In fact GlaxoSmithKline say that when the weight loss drug Xenical was launched people’s expectations were too high and thus when they did use the drug they were disappointed.  GlaxoSmithKline said that they did not want to make the same mistake as Roche had and that’s why they were sounding a cautionary and reserved note with the promotion of Alli.
Mr. Burton from the GlaxoSmithKline Consumer Healthcare division said that they were going out of their way to be honest with exactly how useful Alli could be. A huge amount of money is going into the marketing of Alli in the United States and GlaxoSmithKline say they have earmarked a $150 million just for this year.

© 2008 This content has been exclusively written by UKMedix